TipRanks
Advertisement
Advertisement
Guggenheim downgrades Passage Bio to Neutral, terminates coverage
PremiumThe FlyGuggenheim downgrades Passage Bio to Neutral, terminates coverage
4M ago
Passage Bio downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Passage Bio downgraded to Neutral from Buy at Guggenheim
4M ago
Passage Bio Ends Key Collaborations and Office Lease
Premium
Company Announcements
Passage Bio Ends Key Collaborations and Office Lease
5M ago
Passage Bio downgraded to Hold from Buy at TD Cowen
PremiumThe FlyPassage Bio downgraded to Hold from Buy at TD Cowen
6M ago
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
Premium
The Fly
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
6M ago
Passage Bio price target lowered to $15 from $30 at Oppenheimer
Premium
The Fly
Passage Bio price target lowered to $15 from $30 at Oppenheimer
6M ago
Passage Bio downgraded to Neutral from Buy at Lucid Capital
PremiumThe FlyPassage Bio downgraded to Neutral from Buy at Lucid Capital
6M ago
Passage Bio Announces PBFT02 Data and Strategic Review
Premium
Company Announcements
Passage Bio Announces PBFT02 Data and Strategic Review
6M ago
Passage Bio reports updated interim data from upliFT-D trial
Premium
The Fly
Passage Bio reports updated interim data from upliFT-D trial
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―